Skip to search formSkip to main contentSkip to account menu

FK778

Known as: FK 778, FK-778 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The induction of transplantation tolerance involves a T-cell-mediated process of immune regulation. In clinical transplantation… 
2006
2006
This study examined the efficacies of sirolimus and the novel immunosuppressive agent FK778 to prevent obliterative airway… 
2005
2005
Background. FK778 is a malononitrilamide, a class of immune suppressive compounds with antiviral features and experimental… 
2005
2005
Background. FK778, a derivative of the active leflunomide-metabolite, A77 1726, has been shown to be a powerful immunosuppressant… 
2004
2004
Objective. The synthetic malononitrilamide FK778 inhibits T- and B-cell responsiveness, phagocyte effector function, exerts… 
2003
2003
Background. The effects of tacrolimus (FK506) and malononitrilamides (MNA) (FK778 and FK779) monotherapy and combination therapy… 
2003
2003
Background. The leflunomide analog, FK778, is a selective pyrimidine synthesis inhibitor. In rodent models, FK778 is efficacious… 
Highly Cited
2002
Highly Cited
2002
BACKGROUND Leflunomide and its metabolite, A77 1726, interfere with pyrimidine metabolism and exert potent immunosuppression in…